Valuation: Boston Scientific Corporation

Market Cap 75.37B 64.66B 60.37B 55.39B 104B 7,204B 106B 712B 279B 3,613B 283B 277B 11,947B P/E 2026 *
19.5x
P/E 2027 * 20.2x
Enterprise Value 84.09B 72.13B 67.36B 61.8B 116B 8,038B 118B 795B 311B 4,031B 316B 309B 13,328B EV / Sales 2026 *
3.94x
EV / Sales 2027 * 3.62x
Free-Float
82.47%
Yield 2026 *
-
Yield 2027 * -
1 day+0.94%
1 week+1.15%
Current month+11.30%
1 month+18.12%
3 months-8.45%
6 months-31.31%
Current year-45.45%
1 week 50.45
Extreme 50.45
52.99
1 month 42.5
Extreme 42.5
52.99
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
11/08/26 Other

Controller/Auditor

2,930 0.0002%
10/08/26 Other

Chief Financial Officer

9,908 0.0007%
05/08/26 Buy

Director

2,100 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+3.05%+1.15%-49.87%+3.63% 75.37B
+4.16%+1.75%+23.13%+15.24% 227B
+5.97%+2.77%-0.33%-15.87% 149B
+1.67%-0.88%-17.00%+39.09% 141B
+1.43%-0.83%+16.91%+20.50% 53.19B
+1.32%+2.43%-16.15%-12.15% 51.88B
+4.70%+4.84%+29.39%+30.32% 43.89B
+3.64%-0.07%+39.67%+54.01% 40.86B
+2.74%+3.24%+0.88%+9.16% 33.7B
+4.85%+2.06%-19.36%+39.22% 33.27B
Average +3.00%+1.44%+0.73%+18.32% 84.82B
Weighted average by Cap. +3.32%+1.34%+1.66%+14.71%

Financials

2026 *2027 *
Net sales 21.37B 18.33B 17.11B 15.7B 29.53B 2,042B 30.01B 202B 79.08B 1,024B 80.23B 78.48B 3,386B 22.34B 19.16B 17.89B 16.42B 30.87B 2,135B 31.38B 211B 82.67B 1,071B 83.87B 82.05B 3,540B
Net income 3.84B 3.3B 3.08B 2.82B 5.31B 367B 5.4B 36.32B 14.22B 184B 14.43B 14.12B 609B 3.74B 3.21B 2.99B 2.75B 5.17B 357B 5.25B 35.34B 13.84B 179B 14.04B 13.73B 593B
Net Debt 8.72B 7.48B 6.98B 6.41B 12.05B 833B 12.24B 82.39B 32.26B 418B 32.73B 32.02B 1,382B 5.45B 4.68B 4.37B 4.01B 7.53B 521B 7.66B 51.53B 20.18B 261B 20.47B 20.02B 864B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
19/08/26 $52.01 +3.05% 16,834,155
18/08/26 $50.47 -1.87% 11,724,272
17/08/26 $51.43 -0.77% 18,151,325
14/08/26 $51.83 +0.27% 16,297,739
13/08/26 $51.69 +0.53% 15,699,989
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
52.01USD
Average target price
62.69USD
Spread / Average Target
+20.53%

Quarterly revenue - Rate of surprise